 | • レポートコード：20QY06-04963 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、癌幹細胞（CSC）のグローバル市場について種類別（セルサーチ、その他）、用途別（乳癌診断及び治療、前立腺癌診断及び治療、結腸直腸癌診断及び治療、肺癌診断及び治療、その他の癌診断及び治療）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・癌幹細胞（CSC）市場の概要 ・世界の主要地域別癌幹細胞（CSC）市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の癌幹細胞（CSC）市場規模2015-2026：種類別（セルサーチ、その他） ・世界の癌幹細胞（CSC）市場規模2015-2026：用途別（乳癌診断及び治療、前立腺癌診断及び治療、結腸直腸癌診断及び治療、肺癌診断及び治療、その他の癌診断及び治療） ・癌幹細胞（CSC）の北米市場規模2015-2020 ・癌幹細胞（CSC）のヨーロッパ市場規模2015-2020 ・癌幹細胞（CSC）の中国市場規模2015-2020 ・癌幹細胞（CSC）の日本市場規模2015-2020 ・癌幹細胞（CSC）の東南アジア市場規模2015-2020 ・癌幹細胞（CSC）のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Janssen、、Qiagen、、Advanced Cell Diagnostics、、ApoCell、、Biofluidica、、Clearbridge Biomedics、、CytoTrack、、Celsee、、Fluxion、、Gilupi、、Cynvenio、、On-chip、、YZY Bio、、BioView、、Creatv MicroTech、、Fluidigm、、Ikonisys、、AdnaGen、、IVDiagnostics、、Miltenyi Biotec、、Aviva Biosciences Corporation、、ScreenCell、、Silicon Biosystems、） ・癌幹細胞（CSC）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・癌幹細胞（CSC）の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Cancer Stem Cells (CSCs) Market
The global Cancer Stem Cells (CSCs) market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Cancer Stem Cells (CSCs) Scope and Market Size
The global Cancer Stem Cells (CSCs) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Stem Cells (CSCs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Cancer Stem Cells (CSCs) market is segmented into
CellSearch
Others
Segment by Application, the Cancer Stem Cells (CSCs) market is segmented into
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Other Cancers Diagnosis and Treatment
The Cancer Stem Cells (CSCs) market is analysed and market size information is provided by regions (countries). Segment by Application, the Cancer Stem Cells (CSCs) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cancer Stem Cells (CSCs) Market Share Analysis
Cancer Stem Cells (CSCs) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cancer Stem Cells (CSCs) business, the date to enter into the Cancer Stem Cells (CSCs) market, Cancer Stem Cells (CSCs) product introduction, recent developments, etc.
The major vendors covered:
Janssen
Qiagen
Advanced Cell Diagnostics
ApoCell
Biofluidica
Clearbridge Biomedics
CytoTrack
Celsee
Fluxion
Gilupi
Cynvenio
On-chip
YZY Bio
BioView
Creatv MicroTech
Fluidigm
Ikonisys
AdnaGen
IVDiagnostics
Miltenyi Biotec
Aviva Biosciences Corporation
ScreenCell
Silicon Biosystems
レポート目次Table of Contents
1 Cancer Stem Cells (CSCs) Market Overview
1.1 Cancer Stem Cells (CSCs) Product Scope
1.2 Cancer Stem Cells (CSCs) Segment by Type
1.2.1 Global Cancer Stem Cells (CSCs) Sales by Type (2020-2026)
1.2.2 CellSearch
1.2.3 Others
1.3 Cancer Stem Cells (CSCs) Segment by Application
1.3.1 Global Cancer Stem Cells (CSCs) Sales Comparison by Application (2020-2026)
1.3.2 Breast Cancer Diagnosis and Treatment
1.3.3 Prostate Cancer Diagnosis and Treatment
1.3.4 Colorectal Cancer Diagnosis and Treatment
1.3.5 Lung Cancer Diagnosis and Treatment
1.3.6 Other Cancers Diagnosis and Treatment
1.4 Cancer Stem Cells (CSCs) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Cancer Stem Cells (CSCs) Sales Growth Rate (2015-2026)
1.4.2 Global Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2026)
1.4.3 Global Cancer Stem Cells (CSCs) Price Trends (2015-2026)
2 Cancer Stem Cells (CSCs) Estimate and Forecast by Region
2.1 Global Cancer Stem Cells (CSCs) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Cancer Stem Cells (CSCs) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Cancer Stem Cells (CSCs) Sales Market Share by Region (2015-2020)
2.2.2 Global Cancer Stem Cells (CSCs) Revenue Market Share by Region (2015-2020)
2.3 Global Cancer Stem Cells (CSCs) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Cancer Stem Cells (CSCs) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Cancer Stem Cells (CSCs) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Cancer Stem Cells (CSCs) Estimates and Projections (2015-2026)
2.4.2 Europe Cancer Stem Cells (CSCs) Estimates and Projections (2015-2026)
2.4.3 China Cancer Stem Cells (CSCs) Estimates and Projections (2015-2026)
2.4.4 Japan Cancer Stem Cells (CSCs) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Cancer Stem Cells (CSCs) Estimates and Projections (2015-2026)
2.4.6 India Cancer Stem Cells (CSCs) Estimates and Projections (2015-2026)
3 Global Cancer Stem Cells (CSCs) Competition Landscape by Players
3.1 Global Top Cancer Stem Cells (CSCs) Players by Sales (2015-2020)
3.2 Global Top Cancer Stem Cells (CSCs) Players by Revenue (2015-2020)
3.3 Global Cancer Stem Cells (CSCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Stem Cells (CSCs) as of 2019)
3.4 Global Cancer Stem Cells (CSCs) Average Price by Company (2015-2020)
3.5 Manufacturers Cancer Stem Cells (CSCs) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Cancer Stem Cells (CSCs) Players (Opinion Leaders)
4 Global Cancer Stem Cells (CSCs) Market Size by Type
4.1 Global Cancer Stem Cells (CSCs) Historic Market Review by Type (2015-2020)
4.1.1 Global Cancer Stem Cells (CSCs) Sales Market Share by Type (2015-2020)
4.1.2 Global Cancer Stem Cells (CSCs) Revenue Market Share by Type (2015-2020)
4.1.3 Global Cancer Stem Cells (CSCs) Price by Type (2014-2020)
4.2 Global Cancer Stem Cells (CSCs) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Cancer Stem Cells (CSCs) Sales Forecast by Type (2021-2026)
4.2.2 Global Cancer Stem Cells (CSCs) Revenue Forecast by Type (2021-2026)
4.2.3 Global Cancer Stem Cells (CSCs) Price Forecast by Type (2021-2026)
5 Global Cancer Stem Cells (CSCs) Market Size by Application
5.1 Global Cancer Stem Cells (CSCs) Historic Market Review by Application (2015-2020)
5.1.1 Global Cancer Stem Cells (CSCs) Sales Market Share by Application (2015-2020)
5.1.2 Global Cancer Stem Cells (CSCs) Revenue Market Share by Application (2015-2020)
5.1.3 Global Cancer Stem Cells (CSCs) Price by Application (2015-2020)
5.2 Global Cancer Stem Cells (CSCs) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Cancer Stem Cells (CSCs) Sales Forecast by Application (2021-2026)
5.2.2 Global Cancer Stem Cells (CSCs) Revenue Forecast by Application (2021-2026)
5.2.3 Global Cancer Stem Cells (CSCs) Price Forecast by Application (2021-2026)
3 North America Cancer Stem Cells (CSCs) Market Facts & Figures
3.2 North America Cancer Stem Cells (CSCs) Sales Market Share by Company (2015-2020)
3.3 North America Cancer Stem Cells (CSCs) Sales Market Share by Type (2015-2020)
3.4 North America Cancer Stem Cells (CSCs) Sales Market Share by Application (2015-2020)
4 Europe Cancer Stem Cells (CSCs) Market Facts & Figures
4.2 Europe Cancer Stem Cells (CSCs) Sales Market Share by Company (2015-2020)
4.3 Europe Cancer Stem Cells (CSCs) Sales Market Share by Type (2015-2020)
4.4 Europe Cancer Stem Cells (CSCs) Sales Market Share by Application (2015-2020)
5 China Cancer Stem Cells (CSCs) Market Facts & Figures
5.2 China Cancer Stem Cells (CSCs) Sales Market Share by Company (2015-2020)
5.3 China Cancer Stem Cells (CSCs) Sales Market Share by Type (2015-2020)
5.4 China Cancer Stem Cells (CSCs) Sales Market Share by Application (2015-2020)
6 Japan Cancer Stem Cells (CSCs) Market Facts & Figures
6.2 Japan Cancer Stem Cells (CSCs) Sales Market Share by Company (2015-2020)
6.3 Japan Cancer Stem Cells (CSCs) Sales Market Share by Type (2015-2020)
6.4 Japan Cancer Stem Cells (CSCs) Sales Market Share by Application (2015-2020)
7 Southeast Asia Cancer Stem Cells (CSCs) Market Facts & Figures
7.2 Southeast Asia Cancer Stem Cells (CSCs) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Cancer Stem Cells (CSCs) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Cancer Stem Cells (CSCs) Sales Market Share by Application (2015-2020)
8 India Cancer Stem Cells (CSCs) Market Facts & Figures
8.2 India Cancer Stem Cells (CSCs) Sales Market Share by Company (2015-2020)
8.3 India Cancer Stem Cells (CSCs) Sales Market Share by Type (2015-2020)
8.4 India Cancer Stem Cells (CSCs) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Cancer Stem Cells (CSCs) Business
12.1 Janssen
12.1.1 Janssen Cancer Stem Cells (CSCs) Corporation Information
12.1.2 Janssen Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.1.3 Janssen Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Janssen Cancer Stem Cells (CSCs) Products Offered
12.1.5 Janssen Recent Development
12.2 Qiagen
12.2.1 Qiagen Cancer Stem Cells (CSCs) Corporation Information
12.2.2 Qiagen Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.2.3 Qiagen Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Qiagen Cancer Stem Cells (CSCs) Products Offered
12.2.5 Qiagen Recent Development
12.3 Advanced Cell Diagnostics
12.3.1 Advanced Cell Diagnostics Cancer Stem Cells (CSCs) Corporation Information
12.3.2 Advanced Cell Diagnostics Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.3.3 Advanced Cell Diagnostics Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Advanced Cell Diagnostics Cancer Stem Cells (CSCs) Products Offered
12.3.5 Advanced Cell Diagnostics Recent Development
12.4 ApoCell
12.4.1 ApoCell Cancer Stem Cells (CSCs) Corporation Information
12.4.2 ApoCell Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.4.3 ApoCell Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 ApoCell Cancer Stem Cells (CSCs) Products Offered
12.4.5 ApoCell Recent Development
12.5 Biofluidica
12.5.1 Biofluidica Cancer Stem Cells (CSCs) Corporation Information
12.5.2 Biofluidica Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.5.3 Biofluidica Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Biofluidica Cancer Stem Cells (CSCs) Products Offered
12.5.5 Biofluidica Recent Development
12.6 Clearbridge Biomedics
12.6.1 Clearbridge Biomedics Cancer Stem Cells (CSCs) Corporation Information
12.6.2 Clearbridge Biomedics Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.6.3 Clearbridge Biomedics Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Clearbridge Biomedics Cancer Stem Cells (CSCs) Products Offered
12.6.5 Clearbridge Biomedics Recent Development
12.7 CytoTrack
12.7.1 CytoTrack Cancer Stem Cells (CSCs) Corporation Information
12.7.2 CytoTrack Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.7.3 CytoTrack Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 CytoTrack Cancer Stem Cells (CSCs) Products Offered
12.7.5 CytoTrack Recent Development
12.8 Celsee
12.8.1 Celsee Cancer Stem Cells (CSCs) Corporation Information
12.8.2 Celsee Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.8.3 Celsee Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Celsee Cancer Stem Cells (CSCs) Products Offered
12.8.5 Celsee Recent Development
12.9 Fluxion
12.9.1 Fluxion Cancer Stem Cells (CSCs) Corporation Information
12.9.2 Fluxion Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.9.3 Fluxion Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Fluxion Cancer Stem Cells (CSCs) Products Offered
12.9.5 Fluxion Recent Development
12.10 Gilupi
12.10.1 Gilupi Cancer Stem Cells (CSCs) Corporation Information
12.10.2 Gilupi Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.10.3 Gilupi Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Gilupi Cancer Stem Cells (CSCs) Products Offered
12.10.5 Gilupi Recent Development
12.11 Cynvenio
12.11.1 Cynvenio Cancer Stem Cells (CSCs) Corporation Information
12.11.2 Cynvenio Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.11.3 Cynvenio Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Cynvenio Cancer Stem Cells (CSCs) Products Offered
12.11.5 Cynvenio Recent Development
12.12 On-chip
12.12.1 On-chip Cancer Stem Cells (CSCs) Corporation Information
12.12.2 On-chip Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.12.3 On-chip Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.12.4 On-chip Cancer Stem Cells (CSCs) Products Offered
12.12.5 On-chip Recent Development
12.13 YZY Bio
12.13.1 YZY Bio Cancer Stem Cells (CSCs) Corporation Information
12.13.2 YZY Bio Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.13.3 YZY Bio Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.13.4 YZY Bio Cancer Stem Cells (CSCs) Products Offered
12.13.5 YZY Bio Recent Development
12.14 BioView
12.14.1 BioView Cancer Stem Cells (CSCs) Corporation Information
12.14.2 BioView Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.14.3 BioView Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.14.4 BioView Cancer Stem Cells (CSCs) Products Offered
12.14.5 BioView Recent Development
12.15 Creatv MicroTech
12.15.1 Creatv MicroTech Cancer Stem Cells (CSCs) Corporation Information
12.15.2 Creatv MicroTech Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.15.3 Creatv MicroTech Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Creatv MicroTech Cancer Stem Cells (CSCs) Products Offered
12.15.5 Creatv MicroTech Recent Development
12.16 Fluidigm
12.16.1 Fluidigm Cancer Stem Cells (CSCs) Corporation Information
12.16.2 Fluidigm Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.16.3 Fluidigm Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Fluidigm Cancer Stem Cells (CSCs) Products Offered
12.16.5 Fluidigm Recent Development
12.17 Ikonisys
12.17.1 Ikonisys Cancer Stem Cells (CSCs) Corporation Information
12.17.2 Ikonisys Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.17.3 Ikonisys Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Ikonisys Cancer Stem Cells (CSCs) Products Offered
12.17.5 Ikonisys Recent Development
12.18 AdnaGen
12.18.1 AdnaGen Cancer Stem Cells (CSCs) Corporation Information
12.18.2 AdnaGen Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.18.3 AdnaGen Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.18.4 AdnaGen Cancer Stem Cells (CSCs) Products Offered
12.18.5 AdnaGen Recent Development
12.19 IVDiagnostics
12.19.1 IVDiagnostics Cancer Stem Cells (CSCs) Corporation Information
12.19.2 IVDiagnostics Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.19.3 IVDiagnostics Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.19.4 IVDiagnostics Cancer Stem Cells (CSCs) Products Offered
12.19.5 IVDiagnostics Recent Development
12.20 Miltenyi Biotec
12.20.1 Miltenyi Biotec Cancer Stem Cells (CSCs) Corporation Information
12.20.2 Miltenyi Biotec Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.20.3 Miltenyi Biotec Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Miltenyi Biotec Cancer Stem Cells (CSCs) Products Offered
12.20.5 Miltenyi Biotec Recent Development
12.21 Aviva Biosciences Corporation
12.21.1 Aviva Biosciences Corporation Cancer Stem Cells (CSCs) Corporation Information
12.21.2 Aviva Biosciences Corporation Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.21.3 Aviva Biosciences Corporation Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Aviva Biosciences Corporation Cancer Stem Cells (CSCs) Products Offered
12.21.5 Aviva Biosciences Corporation Recent Development
12.22 ScreenCell
12.22.1 ScreenCell Cancer Stem Cells (CSCs) Corporation Information
12.22.2 ScreenCell Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.22.3 ScreenCell Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.22.4 ScreenCell Cancer Stem Cells (CSCs) Products Offered
12.22.5 ScreenCell Recent Development
12.23 Silicon Biosystems
12.23.1 Silicon Biosystems Cancer Stem Cells (CSCs) Corporation Information
12.23.2 Silicon Biosystems Cancer Stem Cells (CSCs) Business Overview and Total Revenue
12.23.3 Silicon Biosystems Cancer Stem Cells (CSCs) Sales, Revenue and Gross Margin (2015-2020)
12.23.4 Silicon Biosystems Cancer Stem Cells (CSCs) Products Offered
12.23.5 Silicon Biosystems Recent Development
13 Cancer Stem Cells (CSCs) Manufacturing Cost Analysis
13.1 Cancer Stem Cells (CSCs) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Cancer Stem Cells (CSCs)
13.4 Cancer Stem Cells (CSCs) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Cancer Stem Cells (CSCs) Distributors List
14.3 Cancer Stem Cells (CSCs) Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of TablesTable 1. Global Cancer Stem Cells (CSCs) Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Cancer Stem Cells (CSCs) Sales (K Units) Comparison by Application (2020-2026)
Table 3. Global Market Cancer Stem Cells (CSCs) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Cancer Stem Cells (CSCs) Sales (K Units) by Region (2015-2020)
Table 5. Global Cancer Stem Cells (CSCs) Sales Market Share by Region (2015-2020)
Table 6. Global Cancer Stem Cells (CSCs) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Cancer Stem Cells (CSCs) Revenue Share by Region (2015-2020)
Table 8. Global Cancer Stem Cells (CSCs) Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Cancer Stem Cells (CSCs) Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Cancer Stem Cells (CSCs) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Cancer Stem Cells (CSCs) Revenue Share Forecast by Region (2021-2026)
Table 12. Global Cancer Stem Cells (CSCs) (K Units) of Key Companies (2015-2020)
Table 13. Global Cancer Stem Cells (CSCs) Sales Share by Company (2015-2020)
Table 14. Global Cancer Stem Cells (CSCs) Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Cancer Stem Cells (CSCs) Revenue Share by Company (2015-2020)
Table 16. Global Cancer Stem Cells (CSCs) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Stem Cells (CSCs) as of 2019)
Table 17. Global Cancer Stem Cells (CSCs) Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Cancer Stem Cells (CSCs) Manufacturing Sites and Area Served
Table 19. Manufacturers Cancer Stem Cells (CSCs) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Cancer Stem Cells (CSCs) Players
Table 22. Global Cancer Stem Cells (CSCs) Sales (K Units) by Type (2015-2020)
Table 23. Global Cancer Stem Cells (CSCs) Sales Share by Type (2015-2020)
Table 24. Global Cancer Stem Cells (CSCs) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Cancer Stem Cells (CSCs) Price (K Units) by Type (2015-2020)
Table 26. Global Cancer Stem Cells (CSCs) Sales Share by Type (2021-2026)
Table 27. Global Cancer Stem Cells (CSCs) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Cancer Stem Cells (CSCs) Revenue Share by Type (2021-2026)
Table 29. Global Cancer Stem Cells (CSCs) Price (K Units) by Type (2021-2026)
Table 30. Global Cancer Stem Cells (CSCs) Sales (K Units) by Application (2015-2020)
Table 31. Global Cancer Stem Cells (CSCs) Sales Share by Application (2015-2020)
Table 32. Global Cancer Stem Cells (CSCs) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Cancer Stem Cells (CSCs) Price (K Units) by Application (2015-2020)
Table 34. Global Cancer Stem Cells (CSCs) Sales (K Units) by Application (2021-2026)
Table 35. Global Cancer Stem Cells (CSCs) Sales Share by Application (2021-2026)
Table 36. Global Cancer Stem Cells (CSCs) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Cancer Stem Cells (CSCs) Revenue Share by Application (2021-2026)
Table 38. Global Cancer Stem Cells (CSCs) Price (K Units) by Application (2021-2026)
Table 39. United States Cancer Stem Cells (CSCs) Sales (K Units) by Company (2015-2020)
Table 40. United States Cancer Stem Cells (CSCs) Sales Market Share by Company (2015-2020)
Table 41. United States Cancer Stem Cells (CSCs) Sales (K Units) by Type (2015-2020)
Table 42. United States Cancer Stem Cells (CSCs) Sales Market Share by Type (2015-2020)
Table 43. United States Cancer Stem Cells (CSCs) Sales (K Units) by Application (2015-2020)
Table 44. United States Cancer Stem Cells (CSCs) Sales Market Share by Application (2015-2020)
Table 45. Europe Cancer Stem Cells (CSCs) Sales (K Units) by Company (2015-2020)
Table 46. Europe Cancer Stem Cells (CSCs) Sales Market Share by Company (2015-2020)
Table 47. Europe Cancer Stem Cells (CSCs) Sales (K Units) by Type (2015-2020)
Table 48. Europe Cancer Stem Cells (CSCs) Sales Market Share by Type (2015-2020)
Table 49. Europe Cancer Stem Cells (CSCs) Sales (K Units) by Application (2015-2020)
Table 50. Europe Cancer Stem Cells (CSCs) Sales Market Share by Type (2015-2020)
Table 51. China Cancer Stem Cells (CSCs) Sales (K Units) by Company (2015-2020)
Table 52. China Cancer Stem Cells (CSCs) Sales Market Share by Company (2015-2020)
Table 53. China Cancer Stem Cells (CSCs) Sales (K Units) by Type (2015-2020)
Table 54. China Cancer Stem Cells (CSCs) Sales Market Share by Type (2015-2020)
Table 55. China Cancer Stem Cells (CSCs) Sales (K Units) by Application (2015-2020)
Table 56. China Cancer Stem Cells (CSCs) Sales Market Share by Application (2015-2020)
Table 57. Japan Cancer Stem Cells (CSCs) Sales (K Units) by Company (2015-2020)
Table 58. Japan Cancer Stem Cells (CSCs) Sales Market Share by Company (2015-2020)
Table 59. Japan Cancer Stem Cells (CSCs) Sales (K Units) by Type (2015-2020)
Table 60. Japan Cancer Stem Cells (CSCs) Sales Market Share by Type (2015-2020)
Table 61. Japan Cancer Stem Cells (CSCs) Sales (K Units) by Application (2015-2020)
Table 62. Japan Cancer Stem Cells (CSCs) Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Cancer Stem Cells (CSCs) Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Cancer Stem Cells (CSCs) Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Cancer Stem Cells (CSCs) Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Cancer Stem Cells (CSCs) Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Cancer Stem Cells (CSCs) Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Cancer Stem Cells (CSCs) Sales Market Share by Application (2015-2020)
Table 69. India Cancer Stem Cells (CSCs) Sales (K Units) by Company (2015-2020)
Table 70. India Cancer Stem Cells (CSCs) Sales Market Share by Company (2015-2020)
Table 71. India Cancer Stem Cells (CSCs) Sales (K Units) by Type (2015-2020)
Table 72. India Cancer Stem Cells (CSCs) Sales Market Share by Type (2015-2020)
Table 73. India Cancer Stem Cells (CSCs) Sales (K Units) by Application (2015-2020)
Table 74. India Cancer Stem Cells (CSCs) Sales Market Share by Application (2015-2020)
Table 75. Janssen Corporation Information
Table 76. Janssen Description and Business Overview
Table 77. Janssen Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Janssen Cancer Stem Cells (CSCs) Product
Table 79. Janssen Recent Development
Table 80. Qiagen Corporation Information
Table 81. Qiagen Description and Business Overview
Table 82. Qiagen Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Qiagen Cancer Stem Cells (CSCs) Product
Table 84. Qiagen Recent Development
Table 85. Advanced Cell Diagnostics Corporation Information
Table 86. Advanced Cell Diagnostics Description and Business Overview
Table 87. Advanced Cell Diagnostics Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Advanced Cell Diagnostics Cancer Stem Cells (CSCs) Product
Table 89. Advanced Cell Diagnostics Recent Development
Table 90. ApoCell Corporation Information
Table 91. ApoCell Description and Business Overview
Table 92. ApoCell Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. ApoCell Cancer Stem Cells (CSCs) Product
Table 94. ApoCell Recent Development
Table 95. Biofluidica Corporation Information
Table 96. Biofluidica Description and Business Overview
Table 97. Biofluidica Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Biofluidica Cancer Stem Cells (CSCs) Product
Table 99. Biofluidica Recent Development
Table 100. Clearbridge Biomedics Corporation Information
Table 101. Clearbridge Biomedics Description and Business Overview
Table 102. Clearbridge Biomedics Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Clearbridge Biomedics Cancer Stem Cells (CSCs) Product
Table 104. Clearbridge Biomedics Recent Development
Table 105. CytoTrack Corporation Information
Table 106. CytoTrack Description and Business Overview
Table 107. CytoTrack Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. CytoTrack Cancer Stem Cells (CSCs) Product
Table 109. CytoTrack Recent Development
Table 110. Celsee Corporation Information
Table 111. Celsee Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Celsee Description and Business Overview
Table 113. Celsee Cancer Stem Cells (CSCs) Product
Table 114. Celsee Recent Development
Table 115. Fluxion Corporation Information
Table 116. Fluxion Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Fluxion Description and Business Overview
Table 118. Fluxion Cancer Stem Cells (CSCs) Product
Table 119. Fluxion Recent Development
Table 120. Gilupi Corporation Information
Table 121. Gilupi Description and Business Overview
Table 122. Gilupi Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Gilupi Cancer Stem Cells (CSCs) Product
Table 124. Gilupi Recent Development
Table 125. Cynvenio Corporation Information
Table 126. Cynvenio Description and Business Overview
Table 127. Cynvenio Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Cynvenio Cancer Stem Cells (CSCs) Product
Table 129. Cynvenio Recent Development
Table 130. On-chip Corporation Information
Table 131. On-chip Description and Business Overview
Table 132. On-chip Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. On-chip Cancer Stem Cells (CSCs) Product
Table 134. On-chip Recent Development
Table 135. YZY Bio Corporation Information
Table 136. YZY Bio Description and Business Overview
Table 137. YZY Bio Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. YZY Bio Cancer Stem Cells (CSCs) Product
Table 139. YZY Bio Recent Development
Table 140. BioView Corporation Information
Table 141. BioView Description and Business Overview
Table 142. BioView Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. BioView Cancer Stem Cells (CSCs) Product
Table 144. BioView Recent Development
Table 145. Creatv MicroTech Corporation Information
Table 146. Creatv MicroTech Description and Business Overview
Table 147. Creatv MicroTech Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Creatv MicroTech Cancer Stem Cells (CSCs) Product
Table 149. Creatv MicroTech Recent Development
Table 150. Fluidigm Corporation Information
Table 151. Fluidigm Description and Business Overview
Table 152. Fluidigm Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. Fluidigm Cancer Stem Cells (CSCs) Product
Table 154. Fluidigm Recent Development
Table 155. Ikonisys Corporation Information
Table 156. Ikonisys Description and Business Overview
Table 157. Ikonisys Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. Ikonisys Cancer Stem Cells (CSCs) Product
Table 159. Ikonisys Recent Development
Table 160. AdnaGen Corporation Information
Table 161. AdnaGen Description and Business Overview
Table 162. AdnaGen Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 163. AdnaGen Cancer Stem Cells (CSCs) Product
Table 164. AdnaGen Recent Development
Table 165. IVDiagnostics Corporation Information
Table 166. IVDiagnostics Description and Business Overview
Table 167. IVDiagnostics Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 168. IVDiagnostics Cancer Stem Cells (CSCs) Product
Table 169. IVDiagnostics Recent Development
Table 170. Miltenyi Biotec Corporation Information
Table 171. Miltenyi Biotec Description and Business Overview
Table 172. Miltenyi Biotec Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 173. Miltenyi Biotec Cancer Stem Cells (CSCs) Product
Table 174. Miltenyi Biotec Recent Development
Table 175. Aviva Biosciences Corporation Corporation Information
Table 176. Aviva Biosciences Corporation Description and Business Overview
Table 177. Aviva Biosciences Corporation Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 178. Aviva Biosciences Corporation Cancer Stem Cells (CSCs) Product
Table 179. Aviva Biosciences Corporation Recent Development
Table 180. ScreenCell Corporation Information
Table 181. ScreenCell Description and Business Overview
Table 182. ScreenCell Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 183. ScreenCell Cancer Stem Cells (CSCs) Product
Table 184. ScreenCell Recent Development
Table 185. Silicon Biosystems Corporation Information
Table 186. Silicon Biosystems Description and Business Overview
Table 187. Silicon Biosystems Cancer Stem Cells (CSCs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 188. Silicon Biosystems Cancer Stem Cells (CSCs) Product
Table 189. Silicon Biosystems Recent Development
Table 190. Production Base and Market Concentration Rate of Raw Material
Table 191. Key Suppliers of Raw Materials
Table 192. Cancer Stem Cells (CSCs) Distributors List
Table 193. Cancer Stem Cells (CSCs) Customers List
Table 194. Market Key Trends
Table 195. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 196. Key Challenges
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Stem Cells (CSCs) Product Picture
Figure 2. Global Cancer Stem Cells (CSCs) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Cancer Stem Cells (CSCs) Market Share by Application in 2020 & 2026
Figure 6. Breast Cancer Diagnosis and Treatment Examples
Figure 7. Prostate Cancer Diagnosis and Treatment Examples
Figure 8. Colorectal Cancer Diagnosis and Treatment Examples
Figure 9. Lung Cancer Diagnosis and Treatment Examples
Figure 10. Other Cancers Diagnosis and Treatment Examples
Figure 11. Global Cancer Stem Cells (CSCs) Sales (K Units) Growth Rate (2015-2026)
Figure 12. Global Cancer Stem Cells (CSCs) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Cancer Stem Cells (CSCs) Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 14. Global Cancer Stem Cells (CSCs) Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Cancer Stem Cells (CSCs) Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Cancer Stem Cells (CSCs) Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Cancer Stem Cells (CSCs) Sales (K Units) Growth Rate (2015-2026)
Figure 18. Europe Cancer Stem Cells (CSCs) Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Cancer Stem Cells (CSCs) Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Cancer Stem Cells (CSCs) Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Cancer Stem Cells (CSCs) Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Cancer Stem Cells (CSCs) Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Cancer Stem Cells (CSCs) Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Cancer Stem Cells (CSCs) Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Cancer Stem Cells (CSCs) Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Cancer Stem Cells (CSCs) Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Cancer Stem Cells (CSCs) Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Cancer Stem Cells (CSCs) Players Market Share by Revenue in Cancer Stem Cells (CSCs) 2015 & 2019
Figure 29. Cancer Stem Cells (CSCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Cancer Stem Cells (CSCs) Revenue Share by Type (2015-2020)
Figure 31. Global Cancer Stem Cells (CSCs) Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Cancer Stem Cells (CSCs) Revenue Share by Application (2015-2020)
Figure 33. Global Cancer Stem Cells (CSCs) Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Cancer Stem Cells (CSCs) Sales Market Share by Type in 2019
Figure 35. United States Cancer Stem Cells (CSCs) Sales Market Share by Type in 2019
Figure 36. Europe Cancer Stem Cells (CSCs) Sales Market Share by Company in 2019
Figure 37. Europe Cancer Stem Cells (CSCs) Sales Market Share by Type in 2019
Figure 38. Europe Cancer Stem Cells (CSCs) Sales Market Share by Application in 2019
Figure 39. China Cancer Stem Cells (CSCs) Sales Market Share by Company in 2019
Figure 40. China Cancer Stem Cells (CSCs) Sales Market Share by Type in 2019
Figure 41. China Cancer Stem Cells (CSCs) Sales Market Share by Application in 2019
Figure 42. Japan Cancer Stem Cells (CSCs) Sales Market Share by Company in 2019
Figure 43. Japan Cancer Stem Cells (CSCs) Sales Market Share by Type in 2019
Figure 44. Japan Cancer Stem Cells (CSCs) Sales Market Share by Application in 2019
Figure 45. Southeast Asia Cancer Stem Cells (CSCs) Sales Market Share by Company in 2019
Figure 46. Southeast Asia Cancer Stem Cells (CSCs) Sales Market Share by Type in 2019
Figure 47. Southeast Asia Cancer Stem Cells (CSCs) Sales Market Share by Application in 2019
Figure 48. India Cancer Stem Cells (CSCs) Sales Market Share by Company in 2019
Figure 49. India Cancer Stem Cells (CSCs) Sales Market Share by Type in 2019
Figure 50. India Cancer Stem Cells (CSCs) Sales Market Share by Application in 2019
Figure 51. Janssen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Advanced Cell Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. ApoCell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Biofluidica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Clearbridge Biomedics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. CytoTrack Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Celsee Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Fluxion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Gilupi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Cynvenio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. On-chip Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. YZY Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. BioView Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Creatv MicroTech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Fluidigm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Ikonisys Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. AdnaGen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. IVDiagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Miltenyi Biotec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Aviva Biosciences Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 72. ScreenCell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 73. Silicon Biosystems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 74. Key Raw Materials Price Trend
Figure 75. Manufacturing Cost Structure of Cancer Stem Cells (CSCs)
Figure 76. Manufacturing Process Analysis of Cancer Stem Cells (CSCs)
Figure 77. Cancer Stem Cells (CSCs) Industrial Chain Analysis
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Porter's Five Forces Analysis
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
大腸がん診断＆治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Colorectal Cancer Diagnosis and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …- 人工多能性幹細胞の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Induced Pluripotent Stem Cells market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.7% in the forecast period of 2020 to 2025 and will expected to reach USD 130.7 million by 2025, from USD 84 million in 2019. The Induced P…
- 前立腺がん診断及び治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Prostate Cancer Diagnosis and Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prost…
- 癌抗体薬物コンジュゲートの世界市場レポート2020 Market Analysis and Insights: Global Cancer Antibody Drug Conjugates Market The global Cancer Antibody Drug Conjugates market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Cancer Antibody Drug Conjugates Scope…
- 動物幹細胞療法の世界市場レポート2020 Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three …